Article Information
History
- April 4, 2019.
Article Versions
- You are currently viewing Version 1 of this article (April 4, 2019 - 14:55).
- View Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Antonio Barral1,*,
- Isabel Rollan1,*,
- Hector Sanchez-Iranzo1,2,
- Wajid Jawaid3,
- Claudio Badia-Careaga1,
- Sergio Menchero1,
- Manuel Gomez-Rodriguez1,
- Carlos Torroja1,
- Fatima Sanchez-Cabo1,
- Berthold Göttgens5,
- Miguel Manzanares1,# and
- Julio Sainz de Aja1,4,#
- 1Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC), 28029 Madrid, Spain
- 2EMBL, 69117 Heidelberg, Germany
- 3Addenbrooke’s Hospital, Cambridge University Hospitals NHS Foundation Trust Cambridge Biomedical Campus Cambridge Cambridgeshire CB2 0QQ
- 4Stem Cell Program, Division of Hematology/Oncology, Children’s Hospital Boston, Boston, MA 02115, USA; Department of Genetics, Harvard Medical School, Boston, MA 02115, USA
- 5Department of Haematology, Wellcome and MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge, UK
- ↵#Corresponding author julio.sainzdeaja{at}childrens.harvard.edu & mmanzanares{at}cnic.es
↵* These authors contributed equally to this work.